AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2013
Nov 19, 2013
30826_dirs_2013-11-19_bdaa65f6-f912-4029-8434-a594591d55bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2013-11-15
Reporting Person: Cox John (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-15 | Stock Option (Right to Buy) | $12.91 | A | 24000 | Acquired | 2023-11-15 | Common Stock (24000) | Direct |
Footnotes
F1: 8,000 shares become exercisable on each of 11/15/2014, 11/15/2015 and 11/15/2016.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23